These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8450401)
1. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. Fischl MA; Krown SE; O'Boyle KP; Mitsuyasu R; Miles S; Wernz JC; Volberding PA; Kahn J; Groopman JE; Feinberg J J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):259-64. PubMed ID: 8450401 [TBL] [Abstract][Full Text] [Related]
2. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. Gill PS; Miles SA; Mitsuyasu RT; Montgomery T; McCarthy S; Espina BM; Feldstein M; Levine AM AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090 [TBL] [Abstract][Full Text] [Related]
5. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230 [TBL] [Abstract][Full Text] [Related]
6. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. Harrison M; Tomlinson D; Stewart S J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119 [TBL] [Abstract][Full Text] [Related]
7. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma. Simpson JK; Miller RF; Spittle MF Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358 [TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Coukell AJ; Spencer CM Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848 [TBL] [Abstract][Full Text] [Related]
9. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151 [TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group. Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437 [TBL] [Abstract][Full Text] [Related]
12. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy. Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226 [TBL] [Abstract][Full Text] [Related]
13. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Hengge UR; Brockmeyer NH; Baumann M; Reimann G; Goos M Lancet; 1993 Aug; 342(8869):497. PubMed ID: 8102452 [No Abstract] [Full Text] [Related]
14. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906 [TBL] [Abstract][Full Text] [Related]
16. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. James ND; Coker RJ; Tomlinson D; Harris JR; Gompels M; Pinching AJ; Stewart JS Clin Oncol (R Coll Radiol); 1994; 6(5):294-6. PubMed ID: 7530036 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor. Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360 [TBL] [Abstract][Full Text] [Related]
18. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Gill PS; Rarick MU; Espina B; Loureiro C; Bernstein-Singer M; Akil B; Levine AM Cancer; 1990 Mar; 65(5):1074-8. PubMed ID: 1689209 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Amantea MA; Forrest A; Northfelt DW; Mamelok R Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa. Stein ME; Lachter J; Spencer D; Bezwoda WR Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]